These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 22829011)
1. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation. Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011 [TBL] [Abstract][Full Text] [Related]
2. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219 [TBL] [Abstract][Full Text] [Related]
3. Multiple nevoid basal cell carcinoma syndrome associated with congenital orbital teratoma, caused by a PTCH1 frameshift mutation. Rodrigues AL; Carvalho A; Cabral R; Carneiro V; Gilardi P; Duarte CP; Puente-Prieto J; Santos P; Mota-Vieira L Genet Mol Res; 2014 Jul; 13(3):5654-63. PubMed ID: 25117323 [TBL] [Abstract][Full Text] [Related]
4. Identification of a SUFU germline mutation in a family with Gorlin syndrome. Pastorino L; Ghiorzo P; Nasti S; Battistuzzi L; Cusano R; Marzocchi C; Garrè ML; Clementi M; Scarrà GB Am J Med Genet A; 2009 Jul; 149A(7):1539-43. PubMed ID: 19533801 [TBL] [Abstract][Full Text] [Related]
5. A new germline mutation of the PTCH gene in a Japanese patient with nevoid basal cell carcinoma syndrome associated with meningioma. Tate G; Li M; Suzuki T; Mitsuya T Jpn J Clin Oncol; 2003 Jan; 33(1):47-50. PubMed ID: 12604725 [TBL] [Abstract][Full Text] [Related]
6. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis. Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568 [TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome. Hasan Ali O; Yurchenko AA; Pavlova O; Sartori A; Bomze D; Higgins R; Ring SS; Hartmann F; Bühler D; Fritzsche FR; Jochum W; Navarini AA; Kim A; French LE; Dermitzakis E; Christiano AM; Hohl D; Bickers DR; Nikolaev SI; Flatz L J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):396-402. PubMed ID: 32564428 [TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma and other neoplasms in patients with heterozygous germline SUFU variants: A scoping review. Lee SG; Evans G; Stephen M; Goren R; Bondy M; Goodman S Am J Med Genet A; 2024 Jun; 194(6):e63496. PubMed ID: 38282294 [TBL] [Abstract][Full Text] [Related]
10. Novel PTCH1 mutations in Japanese Nevoid basal cell carcinoma syndrome patients: two familial and three sporadic cases including the first Japanese patient with medulloblastoma. Fujii M; Noguchi K; Urade M; Muraki Y; Moridera K; Kishimoto H; Hashimoto-Tamaoki T; Nakano Y J Hum Genet; 2011 Apr; 56(4):277-83. PubMed ID: 21368767 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma. Slade I; Murray A; Hanks S; Kumar A; Walker L; Hargrave D; Douglas J; Stiller C; Izatt L; Rahman N Fam Cancer; 2011 Jun; 10(2):337-42. PubMed ID: 21188540 [TBL] [Abstract][Full Text] [Related]
12. First evidence of genotype-phenotype correlations in Gorlin syndrome. Evans DG; Oudit D; Smith MJ; Rutkowski D; Allan E; Newman WG; Lear JT J Med Genet; 2017 Aug; 54(8):530-536. PubMed ID: 28596197 [TBL] [Abstract][Full Text] [Related]
13. Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome. Fujii K; Ohashi H; Suzuki M; Hatsuse H; Shiohama T; Uchikawa H; Miyashita T Fam Cancer; 2013 Dec; 12(4):611-4. PubMed ID: 23479190 [TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of keratocystic odontogenic tumors developing in nevoid basal cell carcinoma syndrome. Suzuki M; Nagao K; Hatsuse H; Sasaki R; Saito K; Fujii K; Miyashita T Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):348-53. PubMed ID: 23953420 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis. Pan S; Dong Q; Sun LS; Li TJ Clin Cancer Res; 2010 Jan; 16(2):442-50. PubMed ID: 20068110 [TBL] [Abstract][Full Text] [Related]
16. Ponti G; Manfredini M; Pastorino L; Maccaferri M; Tomasi A; Pellacani G Anticancer Res; 2018 Jan; 38(1):471-476. PubMed ID: 29277811 [TBL] [Abstract][Full Text] [Related]
17. Heterozygous PTCH1 Mutations Impact the Bone Metabolism in Patients With Nevoid Basal Cell Carcinoma Syndrome Likely by Regulating SPARC Expression. Hong Y; Zhang J; Zhang H; Li X; Qu J; Zhai J; Zhang L; Chen F; Li T J Bone Miner Res; 2016 Jul; 31(7):1413-28. PubMed ID: 26890308 [TBL] [Abstract][Full Text] [Related]
18. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors. Sun LS; Li XF; Li TJ J Dent Res; 2008 Jun; 87(6):575-9. PubMed ID: 18502968 [TBL] [Abstract][Full Text] [Related]
19. Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci. Garavelli L; Piemontese MR; Cavazza A; Rosato S; Wischmeijer A; Gelmini C; Albertini E; Albertini G; Forzano F; Franchi F; Carella M; Zelante L; Superti-Furga A Am J Med Genet A; 2013 Nov; 161A(11):2894-901. PubMed ID: 24124115 [TBL] [Abstract][Full Text] [Related]